                         SEQUENCE LISTING

<110>  BLUEALLELE, LLC
 
<120>  METHODS FOR COMPARING EFFICACY OF DONOR MOLECULES

<130>  BA2018-6PRIO

<150>  62/755,463
<151>  2018-11-03

<150>  62/828,520
<151>  2019-04-03

<150>  62/873,264
<151>  2019-07-12

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Target site

<400>  1
aattctgcaa tcctcactct                                                   20


<210>  2
<211>  127
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Donor molecule

<400>  2
catggctcag tgaacaaatt ctgcaatcct cagtgctctg ggcagtgtga gtgcaaaaaa       60

gaagccaaag gacttcagtg tgacacctgc agagaaaact tttatgggtt agatgtcacc      120

aattgta                                                                127


<210>  3
<211>  127
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Donor molecule

<400>  3
taaatttctc cgaagcttta atgatgttgg atgtgagccc tgccagtgta acctccatgg       60

ctcagtgaac aaattctgca atcctcagaa ctctgggcag tgtgagtgca aaaaagaagc      120

caaagga                                                                127


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Target site

<400>  4
gggtgggaaa atagaccaat                                                   20


<210>  5
<211>  168
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Donor molecule

<400>  5
ggtgaggccc tgggcaggtt ggtatcaagg ttacaagaca ggtttaagga gaccaataga       60

aactgggcat gtggagacag agaagactct tgggtttctg ataggcactg actctctctg      120

cctattgcta gcggtctatt ttcccaccct taggctgctg gtggtcta                   168


<210>  6
<211>  163
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Donor molecule

<400>  6
caggttggta tcaaggttac aagacaggtt taaggagacc aatagaaact gggcatgtgg       60

agacagagaa gactcttggg tttctgatag gcactgactc tctctgccta ttgcaggcgg      120

tctattttcc cacccttagg ctgctggtgg tctacccttg gac                        163


<210>  7
<211>  163
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Donor molecule

<400>  7
caggttggta tcaaggttac aagacaggtt taaggagacc aatagaaact gggcatgtgg       60

agacagagaa gactcttggg tttctgatag gcactgactc tctctgccta ttgcctgcgg      120

tctattttcc cacccttagg ctgctggtgg tctacccttg gac                        163


<210>  8
<211>  160
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Donor molecule

<400>  8
gaccaataga aactgggcat gtggagacag agaagactct tgggtttctg ataggcactg       60

actctctctg cctattgcga gcggtctatt ttcccaccct taggctgctg gtggtctacc      120

cttggaccca gaggttcttt gagtcctttg gggatctgtc                            160


<210>  9
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Target site

<400>  9
ggggccacta gggacaggat                                                   20


<210>  10
<211>  63
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Donor molecule

<400>  10
aggcctaagg atggggcttt tctgtcacca gaaatcctgt ccctagtggc cccactgtgg       60

ggt                                                                     63


<210>  11
<211>  123
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Donor molecule

<400>  11
agacccaata tcaggagact aggaaggagg aggcctaagg atggggcttt tctgtcacca       60

gctatcctgt ccctagtggc cccactgtgg ggtggagggg acagataaaa gtacccagaa      120

cca                                                                    123


